Uwe Wank

640 total citations
10 papers, 526 citations indexed

About

Uwe Wank is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Uwe Wank has authored 10 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Uwe Wank's work include Diet and metabolism studies (5 papers), Gastrointestinal motility and disorders (3 papers) and Gastroesophageal reflux and treatments (2 papers). Uwe Wank is often cited by papers focused on Diet and metabolism studies (5 papers), Gastrointestinal motility and disorders (3 papers) and Gastroesophageal reflux and treatments (2 papers). Uwe Wank collaborates with scholars based in Germany and United States. Uwe Wank's co-authors include Martin Katschinski, R. Arnold, J Schirra, Burkhard Göke, C. Weidmann, Theo Schäfer, Burkhard Göke, Jörg Schirra, Rudolf Arnold and M. M. Byrne and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Diabetes.

In The Last Decade

Uwe Wank

10 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uwe Wank Germany	5	354	227	143	118	92	10	526
J Schirra Germany	5	407 1.1×	267 1.2×	189 1.3×	133 1.1×	116 1.3×	7	621
Burkhard Göke Germany	7	409 1.2×	255 1.1×	129 0.9×	102 0.9×	43 0.5×	11	550
Jean‐Baptiste Roberge Canada	5	304 0.9×	195 0.9×	93 0.7×	89 0.8×	31 0.3×	8	453
Leslie Glass United Kingdom	7	242 0.7×	252 1.1×	136 1.0×	99 0.8×	46 0.5×	9	555
Signe Toräng Denmark	9	294 0.8×	252 1.1×	218 1.5×	168 1.4×	31 0.3×	10	553
Roxanne Dutia United States	13	179 0.5×	361 1.6×	355 2.5×	157 1.3×	40 0.4×	19	663
Jürg Lareida Switzerland	2	287 0.8×	145 0.6×	112 0.8×	137 1.2×	11 0.1×	3	412
Lawrence Billing United Kingdom	7	118 0.3×	137 0.6×	60 0.4×	84 0.7×	33 0.4×	8	336
Joerg Schirra Germany	6	340 1.0×	155 0.7×	127 0.9×	80 0.7×	20 0.2×	9	475
Frances Coyle United Kingdom	2	247 0.7×	524 2.3×	526 3.7×	262 2.2×	27 0.3×	3	778

Countries citing papers authored by Uwe Wank

Since Specialization

Citations

This map shows the geographic impact of Uwe Wank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Wank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Wank more than expected).

Fields of papers citing papers by Uwe Wank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Wank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Wank. The network helps show where Uwe Wank may publish in the future.

Co-authorship network of co-authors of Uwe Wank

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Wank. A scholar is included among the top collaborators of Uwe Wank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Wank. Uwe Wank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Schirra, Joerg, Uwe Wank, Rudolf Arnold, Burkhard Goeke, & Martin Katschinski. (2000). GLP-1(7-36)amide (GLP-1) is a physiological regulator of human antro-pyloro-duodenal motility. Gastroenterology. 118(4). A302–A302. 1 indexed citations

2.

Schirra, Joerg, et al.. (2000). GLP-1(7-36)amide (GLP-1) is a physiological inhibitory modulator of interdigestive and postprandial fundic motility. Gastroenterology. 118(4). A301–A301. 1 indexed citations

3.

Byrne, M. M., Uwe Wank, Rudolf Arnold, et al.. (1998). Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance. Diabetes. 47(8). 1259–1265. 45 indexed citations

4.

Wank, Uwe, J Schirra, R. Arnold, Burkhard Göke, & Martin Katschinski. (1998). Effects of GLP-1 on proximal gastric motor and sensory function in human. Gastroenterology. 114. A1190–A1190. 4 indexed citations

5.

Schirra, Jörg, et al.. (1998). Endogenous GLP-1(7-36)amide controls endocrine pancreatic secretion and antroduodenal motility in human. Gastroenterology. 114. A1178–A1178. 2 indexed citations

6.

Schirra, Jörg, et al.. (1997). Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.. PubMed. 109(1). 84–97. 84 indexed citations

7.

Katschinski, Martin, Jörg Schirra, C. Beglinger, et al.. (1996). Intestinal phase of human antro‐pyloro‐duodenal motility: cholinergic and CCK‐mediated regulation. European Journal of Clinical Investigation. 26(7). 574–583. 28 indexed citations

8.

Schirra, J, Martin Katschinski, C. Weidmann, et al.. (1996). Gastric emptying and release of incretin hormones after glucose ingestion in humans.. Journal of Clinical Investigation. 97(1). 92–103. 344 indexed citations

9.

Katschinski, Martin, et al.. (1995). Cisapride Stimulates Human Esophageal Motility. Digestion. 56(2). 153–158. 14 indexed citations

10.

Katschinski, Martin, et al.. (1993). Comparison of cisapride and metoclopramide as oesophageal prokinetics in healthy humans. European Journal of Gastroenterology & Hepatology. 5(9). 677–682. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact